Gerresheimer : Dietmar Siemssen appointed new CEO of Gerresheimer AG

After completing his university studies, Dietmar Siemssen worked in various management positions at Continental from 1994 to 2011, ultimately as head of a joint venture between Continental and Nisshimbo in Yokohama, Japan, and as head of the Chassis and Safety division in Asia. Dietmar Siemssen's studies included a time at Technical University of Darmstadt, where he gained a diploma in industrial engineering specializing in mechanical engineering. He is married with two children and enjoys doing endurance sports.

Speaker of the Management Board and CFO Rainer Beaujean has informed the Supervisory Board that he will not serve the additional three-year term of office offered to him by the Supervisory Board.

'I did not accept the Supervisory Board's offer to extend my contract for another three years,' states Rainer Beaujean. 'Gerresheimer's positioning is excellent, and the major strategic direction of the company has been set. After six years as Gerresheimer CFO, the last seven months of which I spent as Speaker of the Management Board, I have decided to take on new professional challenges. It goes without saying that I will fulfill all obligations under my contract until the end of April.'

Supervisory Board Chairman Dr. Axel Herberg comments: 'We regret Mr. Beaujean's decision, but we respect the choice he has made. Many thanks to Mr. Beaujean for his outstanding service over the past six years. In addition to his role as CFO, he accepted the position of Speaker of the Management Board in February of this year after the surprising departure of the then-CEO. The acquisition of Sensile Medical occurred during this time, a smart strategic move that will allow the company to move forward.'

About Gerresheimer

Gerresheimer is a leading global partner to the pharma and healthcare industries. The company's special glass and plastic products contribute to health and well-being. Gerresheimer is a global organization with about 10,000 employees and manufacturing operations in the local markets, close to customers. With plants in Europe, North and South America and Asia Gerresheimer generates revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging products as well as convenient and safe drug deli¬very systems such as insulin pens, inhalers, pre-fillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuti¬cals with closure and safety systems, plus cosmetic packaging products.